CRESCENT BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
CRESCENT BIOPHARMA, INC. has filed 662 SEC EDGAR filings since 10 Jul 2003

SEC filing history

Showing 176-200 of 658 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
01 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 May 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2024
Reporting date
29 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2024
Reporting date
29 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2024
Reporting date
29 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36177

ARS

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36177

DEF 14A

Filing date
01 Apr 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-278265

S-8

Filing date
27 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36177

PRE 14A

Filing date
22 Mar 2024
Reporting date
01 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87811

NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#3)

Filing date
29 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87811

NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#2)

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87811

SC 13G/A

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87811

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2024
Reporting date
12 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jan 2024
Reporting date
29 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jan 2024
Reporting date
29 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jan 2024
Reporting date
29 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .